![Jeff Caravella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Caravella
Finanzdirektor/CFO bei
ABIOMED, INC.
Profil
Jeff Caravella is currently Chief Financial Officer at ABIOMED, Inc. since 2025.
Formerly, Mr. Caravella was Chief Financial Officer at BioTheryX, Inc. and Chief Financial Officer at Medicenna Therapeutics Corp.
in 2023.
Education includes undergraduate and MBAistration degrees from Syracuse University.
Aktive Positionen von Jeff Caravella
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIOMED, INC. | Finanzdirektor/CFO | 01.01.2025 |
Ehemalige bekannte Positionen von Jeff Caravella
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Finanzdirektor/CFO | 26.10.2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Finanzdirektor/CFO | - |
Ausbildung von Jeff Caravella
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
